In an episode of the “Brain Inspired” podcast, Chris Rozell, director of the Institute for Neuroscience, Neurotechnology, and Society at the Georgia Institute of Technology, discusses a new biomarker to help clinicians and psychiatrists care for patients with treatment-resistant depression. His team uses deep brain stimulation electrodes to record local field potentials and generative explainable AI to predict patients’ recovery trajectories. Rozell also shares his personal backstory and why community and support are so important in the scientific setting.